agilon health, inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
agilon health, inc. (AGL) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $17.96 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-05
- agilon health, inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $17.96M.
- agilon health, inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $29.92M.
- agilon health, inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$188.88M.
- agilon health, inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$110.21M.
- agilon health, inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was -$405.35M.
- agilon health, inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$250.28M.
- agilon health, inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$195.25M.
- agilon health, inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$92.31M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.96M 10-Q · filed 2026-08-05 | $47.87M 10-Q · filed 2026-08-05 | -$141.01M derived: sum of 3 quarters · filed 2026-08-05 | -$251.22M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $29.92M 10-Q · filed 2026-05-06 | -$158.97M derived: sum of 2 quarters · filed 2026-05-06 | -$269.17M derived: sum of 3 quarters · filed 2026-05-06 | -$373.54M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$188.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$299.09M derived: sum of 2 quarters · filed 2026-02-25 | -$403.46M derived: sum of 3 quarters · filed 2026-08-05 | -$405.35M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$110.21M 10-Q · filed 2025-11-04 | -$214.58M derived: sum of 2 quarters · filed 2026-08-05 | -$216.47M 10-Q · filed 2025-11-04 | -$322.89M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$104.37M 10-Q · filed 2026-08-05 | -$106.26M 10-Q · filed 2026-08-05 | -$212.69M derived: sum of 3 quarters · filed 2026-08-05 | -$329.12M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$1.89M 10-Q · filed 2026-05-06 | -$108.32M derived: sum of 2 quarters · filed 2026-05-06 | -$224.75M derived: sum of 3 quarters · filed 2026-05-06 | -$255.41M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$106.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$222.86M derived: sum of 2 quarters · filed 2026-02-25 | -$253.52M derived: sum of 3 quarters · filed 2026-02-25 | -$250.28M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | -$116.43M 10-Q · filed 2025-11-04 | -$147.09M derived: sum of 2 quarters · filed 2025-11-04 | -$143.85M 10-Q · filed 2025-11-04 | -$310.99M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | -$30.66M 10-Q · filed 2025-08-04 | -$27.41M 10-Q · filed 2025-08-04 | -$194.55M derived: sum of 3 quarters · filed 2026-02-25 | -$216.59M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $3.25M 10-Q · filed 2025-05-06 | -$163.89M derived: sum of 2 quarters · filed 2026-02-25 | -$185.93M derived: sum of 3 quarters · filed 2026-02-25 | -$201.96M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | -$167.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$189.18M derived: sum of 2 quarters · filed 2026-02-25 | -$205.20M derived: sum of 3 quarters · filed 2026-02-25 | -$195.25M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | -$22.04M 10-Q · filed 2024-11-07 | -$31.48M 10-Q · filed 2023-11-02 | -$38.06M derived: sum of 2 quarters · filed 2024-11-07 | -$28.11M 10-Q · filed 2024-11-07 | -$32.32M 10-Q · filed 2023-11-02 | -$69.61M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | -$16.03M 10-Q · filed 2024-08-06 | -$16.80M 10-Q · filed 2023-08-03 | -$6.08M 10-Q · filed 2024-08-06 | -$836.00K 10-Q · filed 2023-08-03 | -$47.57M derived: sum of 3 quarters · filed 2025-02-25 | -$78.07M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $9.95M 10-Q · filed 2024-05-07 | $15.96M 10-Q · filed 2023-05-09 | -$31.54M derived: sum of 2 quarters · filed 2025-02-25 | -$62.05M derived: sum of 3 quarters · filed 2025-02-25 | -$83.08M derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2022-12-31 | -$41.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$72.00M derived: sum of 2 quarters · filed 2025-02-25 | -$93.04M derived: sum of 3 quarters · filed 2025-02-25 | -$92.31M 10-K · filed 2025-02-25 | -$107.33M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | -$30.50M 10-Q · filed 2023-11-02 | -$51.54M derived: sum of 2 quarters · filed 2023-11-02 | -$50.81M 10-Q · filed 2023-11-02 | -$86.62M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-06-30 | -$21.04M 10-Q · filed 2023-08-03 | -$20.31M 10-Q · filed 2023-08-03 | -$56.12M derived: sum of 3 quarters · filed 2024-02-27 | -$93.11M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-03-31 | $726.00K 10-Q · filed 2023-05-09 | -$35.08M derived: sum of 2 quarters · filed 2024-02-27 | -$72.07M derived: sum of 3 quarters · filed 2024-02-27 | -$369.40M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | -$35.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$72.80M derived: sum of 2 quarters · filed 2024-02-27 | -$370.13M derived: sum of 3 quarters · filed 2024-02-27 | -$383.86M 10-K · filed 2024-02-27 | -$405.48M 10-K · filed 2022-03-03 | |||
| 2021-09-30 | -$36.99M 10-Q · filed 2022-11-03 | -$334.32M derived: sum of 2 quarters · filed 2022-11-03 | -$348.06M 10-Q · filed 2022-11-03 | -$387.66M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | -$297.33M 10-Q · filed 2022-08-04 | -$311.06M 10-Q · filed 2022-08-04 | -$350.67M derived: sum of 3 quarters · filed 2023-03-01 | -$362.97M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | -$13.74M 10-Q · filed 2022-05-05 | -$53.34M derived: sum of 2 quarters · filed 2023-03-01 | -$65.64M derived: sum of 3 quarters · filed 2023-03-01 | -$69.08M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | -$39.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$51.90M derived: sum of 2 quarters · filed 2023-03-01 | -$55.35M derived: sum of 3 quarters · filed 2023-03-01 | -$63.21M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | -$12.30M 10-Q · filed 2021-10-28 | -$15.75M derived: sum of 2 quarters · filed 2021-10-28 | -$23.61M 10-Q · filed 2021-10-28 | |||||
| 2020-06-30 | -$3.44M 10-Q · filed 2021-08-04 | -$11.31M 10-Q · filed 2021-08-04 | ||||||
| 2020-03-31 | -$7.86M 10-Q · filed 2021-05-26 | |||||||
| 2019-12-31 | -$114.45M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |